[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369059-105":59,"doc-detail-369059-en":135},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":128,"head_meta":130,"extra_data":132,"updated_unix":134},105,"en","a-population-based-matched-cohort-study-of-extra-digestive-cancer-incidence-and-mortality-in-individuals-with-and-without-inflammatory-bowel-disease","A Population-Based Matched Cohort Study of Extra-Digestive Cancer Incidence and Mortality in Individuals With and Without Inflammatory Bowel Disease","","A Population-Based Matched Cohort Study evaluates temporal trends and contemporary risks of extra-digestive (ED) cancer incidence and mortality in individuals with inflammatory bowel disease (IBD) versus age-sex-matched controls without IBD. Using Ontario administrative data, incidence was modeled with age-sex-standardised annual cancer rates from 1994–2020 and quasi-Poisson regression for incidence and mortality rate ratios (SIR, SMR). ED cancer incidence stayed stable in the IBD group but declined in controls, while ED incidence rose after 2010 and mortality was higher in Crohn's disease.",{"@graph":69,"@context":127},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/a-population-based-matched-cohort-study-of-extra-digestive-cancer-incidence-and-mortality-in-individuals-with-and-without-inflammatory-bowel-disease/369059/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/a-population-based-matched-cohort-study-of-extra-digestive-cancer-incidence-and-mortality-in-individuals-with-and-without-inflammatory-bowel-disease/369059.png","ImageObject",300,407,{"name":92,"@type":93},"pixelkiddo","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119,123],{"name":110,"@type":111,"acceptedAnswer":112},"What was the study’s main purpose regarding extra-digestive cancer?","Question",{"text":113,"@type":114},"To examine temporal trends and contemporary risks of extra-digestive (ED) cancers in individuals with IBD and in people without IBD.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How did the study compare participants with and without inflammatory bowel disease?",{"text":118,"@type":114},"It used age-sex-matched controls at a 1:10 ratio without IBD and compared ED cancer incidence and mortality across 1994–2020.",{"name":120,"@type":111,"acceptedAnswer":121},"What were the key findings about ED cancer incidence over time?",{"text":122,"@type":114},"ED cancer incidence was stable among people with IBD but declined among matched controls; after 2010, ED cancer incidence was higher in the IBD group.",{"name":124,"@type":111,"acceptedAnswer":125},"Which group showed higher cancer-related mortality and how was it expressed?",{"text":126,"@type":114},"Cancer-related mortality was specifically higher among those with Crohn’s disease, reported as an SMR of 1.31 compared with matched controls.","https://schema.org",{"og:url":83,"og:type":129,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":131,"canonical":83},"index,follow",{"doc_id":133,"site_id":62},369059,1790198816,{"code":4,"msg":5,"data":136},{"doc_id":133,"user_id":137,"nickname":92,"user_avatar":138,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":139,"file_id":140,"file_url":141,"file_type":142,"file_size":143,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":144,"language":145,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":146,"faqs":147,"seo_title":148,"seo_description":67,"update_tm":149,"read_time":150,"preview_page_count":19,"preview_urls":151},962090883892,"https://ap-avatar.wpscdn.com/avatar/e00115db34f3e0f11b?x-image-process=image/resize,m_fixed,w_180,h_180&k=1790152879550218658","Alimentary Pharmacology & Therapeutics  \nORIGINAL ARTICLE  OPEN ACCESS   \nA Population-Based Matched Cohort Study of  \nExtra-Digestive Cancer Incidence and Mortality in Individuals With and Without Inflammatory Bowel Disease  \nSanjay K. Murthy1,2,3,4 | Faria Ahmed3 | Michael Pugliese4 | Monica Taljaard3,4 | Parul Tandon4,5 | Priscilla Matthews6 | Gilaad G. Kaplan7  | Stephanie Coward7 | Charles N. Bernstein8,9  | Eric I. Benchimol4,10,11,12  | M. Ellen Kuenzig4,13,14 | Laura E. Targownik15,16  | Harminder Singh8,9  | on behalf of the Canadian Gastro-Intestinal Epidemiology Consortium (CanGIEC)  \n1Department of Medicine and School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada | 2The Ottawa Hospital, IBD Centre, Ottawa, Ontario, Canada | 3Ottawa Hospital Research Institute, Clinical Epidemiology Program, Ottawa, Ontario, Canada | 4ICES, Toronto, Ontario, Canada | 5Division of Gastroenterology and Hepatology, University Health Network, University of Toronto, Toronto, Ontario,  \nCanada | 6Department of Medicine, Queens University, Kingston, Ontario, Canada | 7Division of Gastroenterology and Hepatology, Department of Medicine and Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada | 8University of Manitoba IBD Clinical and Research Centre, Winnipeg, Manitoba, Canada | 9Department of Internal Medicine and Community Health Sciences, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada | 10SickKids Inflammatory Bowel Disease Centre, Division of Gastroenterology, Hepatology and Nutrition, The Hospital for Sick Children, Toronto, Ontario, Canada | 11Department of Paediatrics and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada | 12Child Health Evaluative Sciences, SickKids Research Institute, The Hospital for Sick Children, Toronto, Ontario, Canada | 13Department of Epidemiology and Biostatistics and Department of Pediatrics, Western University, London, Ontario, Canada | 14Children's Health Research Institute, London, Ontario, Canada | 15Mount Sinai Hospital IBD Centre,  \nToronto, Ontario, Canada | 16Division of Gastroenterology and Hepatology, University of Toronto, Toronto, Ontario, Canada Correspondence: Sanjay K. Murthy ([smurthy@toh.ca](smurthy@toh.ca))  \nReceived: 23 May 2025 | Revised: 30 June 2025 | Accepted: 16 October 2025  \nHandling Editor: Sreedhar Subramanian  \nFunding: This work was supported by Crohn's and Colitis Canada, Grant-in-Aid of Research. Canadian Institutes of Health Research, \\# DA1-170245.  \nABSTRACT  \nBackground: Trends in extra-digestive (ED) cancer incidence and mortality in inflammatory bowel diseases (IBD) may be changing with newer approaches to management.  \nAims: To study temporal trends and contemporary risks ofED cancers in individuals with and without IBD.  \nMethods: Using population-level administrative data from Ontario, Canada, we studied ED cancer rates among individuals with IBD and age-sex-matched controls (1:10) without IBD between 1994 and 2020. We modelled age-sex-standardised annual cancer incidence (per 100,000 person-years) over time by first-order linear autoregression, and standardised cancer incidence and mortality rate ratios (SIR, SMR) by quasi-Poisson regression.  \nResults: The average annual percentage change (AAPC) in ED cancer incidence was stable among 110,919 people with IBD (0.108%/year; 95% CI, −0.380, 0.599) but declined among 1,109,190 matched controls (−1.39%/year; 95% CI, −1.57, −1.21) . Among those with IBD, AAPC was significant for non-Hodgkin's lymphoma (1.48%/year; 95% CI, 0.161, 2.82), melanoma (1.77%/year; 95% CI, 0.781, 2.77), cervical (2.31%/year; 95% CI, 0.602, 4.10), uterine (4.41%/year; 95% CI, 0.045, 8.96) and thyroid (8.10%/year; 95% CI, 4.31, 12.0) cancers, and statistically greater than controls for cervical, ovarian, lung, and bladder cancers. During 2010–2020, ED c","cbCaibtny81a7hV7","https://ap.wps.com/l/cbCaibtny81a7hV7","pdf",872594,15,"English","# Abstract\n## Background\n## Aims\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"What was the study’s main purpose regarding extra-digestive cancer?\",\"answer\":\"To examine temporal trends and contemporary risks of extra-digestive (ED) cancers in individuals with IBD and in people without IBD.\"},{\"question\":\"How did the study compare participants with and without inflammatory bowel disease?\",\"answer\":\"It used age-sex-matched controls at a 1:10 ratio without IBD and compared ED cancer incidence and mortality across 1994–2020.\"},{\"question\":\"What were the key findings about ED cancer incidence over time?\",\"answer\":\"ED cancer incidence was stable among people with IBD but declined among matched controls; after 2010, ED cancer incidence was higher in the IBD group.\"},{\"question\":\"Which group showed higher cancer-related mortality and how was it expressed?\",\"answer\":\"Cancer-related mortality was specifically higher among those with Crohn’s disease, reported as an SMR of 1.31 compared with matched controls.\"}]","A Population-Based Matched Cohort Study of Extra-Digestive Cancer Incidence and Mortality in Individuals With and Without Inflammatory Bowel Disease | PDF",1790180438,38,[152,156,160,164],{"page_no":8,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0cf8c2171fab954e187d95afa1e32538.webp",983,1291,{"page_no":14,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fe839f12aa452c4e0ac7578c082ace0e.webp",982,1290,{"page_no":81,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f1d8454d5a0218ca89cbd112e651b1c5.webp",981,1289,{"page_no":19,"url":165,"width":166,"height":167},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b3145a77c27526c30cc46ac39079e2d3.webp",980,1287]